Related Experiment Videos
Developmental delay in children: assessment with proton MR spectroscopy
Christopher G Filippi1, Aziz M Uluğ, Michael D F Deck
1Department of Radiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, NY 10021, USA.
AJNR. American Journal of Neuroradiology
|May 15, 2002
Summary
Proton MR spectroscopy can detect abnormalities in children over 2 years old with developmental delay, even with normal brain MR images. This technique may aid in diagnosis and predicting long-term outcomes.
Area of Science:
- Neuroscience
- Radiology
- Pediatrics
Background:
- Developmental delay often has an unknown cause, leading to frustration for clinicians and families.
- Lack of neuroimaging correlation complicates therapeutic decisions and prognosis.
- Proton MR spectroscopy (MRS) is explored for detecting abnormalities in structurally normal brains.
Purpose of the Study:
- To determine if proton MR spectroscopy can identify abnormalities in children with developmental delay and normal brain MRI.
- To assess the utility of proton MRS in cases where conventional neuroimaging is inconclusive.
Main Methods:
- Brain MRI and proton MR spectroscopy were performed on children with developmental delay (≤2 years and >2 years) and age-matched controls.
- Spectroscopy voxels were placed in the subcortical white matter of frontal and parieto-occipital lobes.
- Ratios of N-acetylaspartate (NAA)/creatine (Cr) and choline (Cho)/Cr were analyzed.
Main Results:
- No significant differences in NAA/Cr or Cho/Cr ratios were found in children ≤2 years old compared to controls.
- Children >2 years old with developmental delay showed decreased NAA/Cr ratios in frontal and parieto-occipital white matter.
- Elevated Cho/Cr ratios were observed in the frontal and parieto-occipital white matter of children >2 years old.
Conclusions:
- Proton MR spectroscopy revealed abnormalities in NAA/Cr and Cho/Cr ratios in children over 2 years old with developmental delay.
- Proton MR spectroscopy should be integrated into the neuroimaging evaluation for developmental delay.
- Further research is needed to establish proton MRS as a diagnostic tool and prognostic marker.